Names before prices
Is the advertised medicine approved?
Get the full name in writing. A price comparison is easier to read when the products being compared are clear.
US approval and custom-medicine rules were checked on September 26, 2026.
Which names have approved products?
Wegovy and Ozempic (semaglutide), plus Zepbound and Mounjaro (tirzepatide), are US products with Food and Drug Administration (FDA) approval.
Each approved product has named uses, such as diabetes or weight care. Ask whether your reason for taking it is one of those uses.
BPC-157, ipamorelin and retatrutide had no approved US product in the FDA records checked on September 26, 2026.
What is this medicine’s complete name? Has the US drug agency approved it for the problem we are trying to treat?
Is a custom version a generic?
Approval as a copy of a drug sold under a brand name makes a medicine a generic.
On September 26, 2026, US marketing was not allowed for any generic version of semaglutide or tirzepatide.
A compounded version—a custom preparation—is not an approved generic.
The FDA identifies claims that a compounded drug is the same as an approved drug as misleading.
Does a research label make it a care option?
Two labels to watch for are “not for human consumption” and “for research purposes.”
FDA warns against buying those products for weight treatment. These products may harm people, and their quality has not been established.
FDA also states that federal law bars retatrutide and cagrilintide from use in compounding.
An NDC number identifies a drug product in a government list. A seller may show that number or listing as proof of approval, but it does not prove FDA approval.
Spot misleading claims